Prof. Michele Orditura
Prof. Michele Orditura
Oncologia Medica Seconda Universitą Napoli
Verified email at unina2.it
TitleCited byYear
Pathogenesis, prevention, diagnosis and treatment of breast cancer
R Shah, K Rosso, SD Nathanson
World journal of clinical oncology 5 (3), 283, 2014
370*2014
Treatment of gastric cancer
M Orditura, G Galizia, V Sforza, V Gambardella, A Fabozzi, MM Laterza, ...
World journal of gastroenterology: WJG 20 (7), 1635, 2014
3482014
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
F De Vita, M Orditura, E Matano, R Bianco, C Carlomagno, S Infusino, ...
British journal of cancer 92 (9), 1644, 2005
3082005
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer …
E Lieto, F Ferraraccio, M Orditura, P Castellano, A La Mura, M Pinto, ...
Annals of surgical oncology 15 (1), 69-79, 2008
2802008
Anti‐epidermal growth factor receptor monoclonal antibodies in cancer therapy
E Martinelli, R De Palma, M Orditura, F De Vita, F Ciardiello
Clinical & Experimental Immunology 158 (1), 1-9, 2009
2502009
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery
G Galizia, M Orditura, C Romano, E Lieto, P Castellano, L Pelosio, ...
Clinical immunology 102 (2), 169-178, 2002
2002002
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery
G Galizia, E Lieto, M Orditura, P Castellano, A La Mura, V Imperatore, ...
World journal of surgery 31 (7), 1458-1468, 2007
1732007
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
F De Vita, M Orditura, G Galizia, C Romano, A Roscigno, E Lieto, ...
Chest 117 (2), 365-373, 2000
1592000
Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery
G Galizia, E Lieto, F Ferraraccio, F De Vita, P Castellano, M Orditura, ...
Annals of surgical oncology 13 (6), 823-835, 2006
1502006
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer
G Galizia, E Lieto, F De Vita, M Orditura, P Castellano, T Troiani, ...
Oncogene 26 (25), 3654, 2007
1482007
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma
F De Vita, M Orditura, E Lieto, S Infusino, F Morgillo, E Martinelli, ...
Cancer 100 (2), 270-278, 2004
1452004
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors
MP Morelli, T Cascone, T Troiani, F De Vita, M Orditura, G Laus, ...
Annals of Oncology 16 (suppl_4), iv61-iv68, 2005
1412005
Determination of molecular marker expression can predict clinical outcome in colon carcinomas
G Galizia, E Lieto, F Ferraraccio, M Orditura, F De Vita, P Castellano, ...
Clinical cancer research 10 (10), 3490-3499, 2004
1382004
First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases
G Galizia, E Lieto, M Orditura, P Castellano, V Imperatore, M Pinto, ...
Archives of Surgery 143 (4), 352-358, 2008
1252008
The role of EGFR inhibitors in nonsmall cell lung cancer
F Ciardiello, F De Vita, M Orditura, G Tortora
Current opinion in oncology 16 (2), 130-135, 2004
1232004
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy
F Ciardiello, T Troiani, R Bianco, M Orditura, F Morgillo, E Martinelli, ...
Annals of Oncology 17 (suppl_7), vii109-vii114, 2006
1122006
Targeting EGFR in pancreatic cancer treatment
T Troiani, E Martinelli, A Capasso, F Morgillo, M Orditura, F De Vita, ...
Current drug targets 13 (6), 802-810, 2012
1052012
Serum interleukin‐10 levels in patients with advanced gastrointestinal malignancies
F De Vita, M Orditura, G Galizia, C Romano, S Infusino, A Auriemma, ...
Cancer 86 (10), 1936-1943, 1999
1031999
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
F Ciardiello, T Troiani, F Caputo, M De Laurentiis, G Tortora, G Palmieri, ...
British journal of cancer 94 (11), 1604, 2006
1022006
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo …
F De Vita, F Giuliani, M Orditura, E Maiello, G Galizia, N Di Martino, ...
Annals of oncology 18 (8), 1354-1358, 2007
992007
The system can't perform the operation now. Try again later.
Articles 1–20